PMID: 16503866Mar 1, 2006Paper

Inhibitors of acyl-coenzyme a: cholesterol acyltransferase

Current Drug Targets. Cardiovascular & Haematological Disorders
Akira MiyazakiTakuya Watanabe

Abstract

Acyl-coenzyme A: cholesterol acyltransferase (ACAT) is an intracellular enzyme that catalyzes the formation of cholesterol esters from cholesterol and fatty acyl-coenzyme A. Animal experiments showed that ACAT inhibitors reduce plasma cholesterol levels by suppressing absorption of dietary cholesterol and by suppressing the assembly and secretion of apolipoprotein B-containing lipoproteins such as very low density lipoprotein in liver and chylomicron in intestine. Moreover, ACAT inhibitors were shown to prevent formation of macrophage-derived foam cells in the arterial walls. However, a recent double-blind, placebo-controlled, randomized trial of a potent ACAT inhibitor, avasimibe, failed to show significant beneficial effects on coronary atherosclerosis assessed by intravascular ultrasound. For clinical application of ACAT inhibitors, development of more potent compounds and improvements of the methods to evaluate their clinical efficacy are strongly needed.

Citations

Oct 31, 2008·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Tomoko KanomeAkira Miyazaki
Nov 22, 2011·Future Medicinal Chemistry·Taichi Ohshiro, Hiroshi Tomoda
Mar 1, 2014·International Journal of Molecular Sciences·Dong-Feng WuWu-Xian Chen
Jun 1, 2006·Expert Review of Neurotherapeutics·Walter J Lukiw
Jun 10, 2008·Expert Opinion on Emerging Drugs·Walter J Lukiw
Jan 6, 2010·Journal of Neurochemistry·Ian J MartinsRalph N Martins
Apr 26, 2016·European Journal of Medicinal Chemistry· Shagufta, Irshad Ahmad
Oct 30, 2016·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·John F Reichard, Lynne T Haber
Mar 20, 2018·Journal of Lipid Research·Yuyan ZhuKee-Hong Kim
Jul 10, 2014·The Journal of Antibiotics·Daisuke MatsudaHiroshi Tomoda
Jul 13, 2006·Current Opinion in Lipidology·Marijn C MeuweseJohn J P Kastelein
Jul 6, 2010·Natural Product Reports·István MolnárStuart B Krasnoff
Oct 21, 2010·Natural Product Reports·Roderich SüssmuthIstván Molnár
Oct 14, 2014·Fungal biology and biotechnology·Lennart RichterVera Meyer
Apr 21, 2010·Bioorganic & Medicinal Chemistry Letters·Honggang HuQiuye Wu

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.